Science Daily1d
Research using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials
Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...
MedPage Today2d
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
Marketing Dive2d
Bayer Achieves 32% Increase in Media Efficiency With Incremental and Skai
“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...
Campaign US2d
Exclusive: How Bayer cracked the retail media code
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...
FiercePharma3d
JPM25: Bayer gears up for 'must-win battles' as Xarelto's decline is in full swing, pharma chief says
These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...
Aspirin Industry Eyes $2.1 Billion Valuation by 2030: Tablets Will Continue to Dominate, Maintaining Around 60-65% Market Share
Investments in R&D and market expansion, particularly in emerging regions, will be crucial in shaping the future of the aspirin marketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Aspirin Global ...